Intuitive Surgical, Inc. $ISRG Stake Boosted by Braidwell LP

Braidwell LP lifted its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 45.3% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 130,227 shares of the medical equipment provider’s stock after acquiring an additional 40,627 shares during the quarter. Intuitive Surgical makes up 1.7% of Braidwell LP’s portfolio, making the stock its 19th biggest holding. Braidwell LP’s holdings in Intuitive Surgical were worth $58,241,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also modified their holdings of the company. Kilter Group LLC acquired a new stake in Intuitive Surgical during the second quarter valued at $27,000. Greykasell Wealth Strategies Inc. acquired a new position in Intuitive Surgical in the 3rd quarter worth about $27,000. Caitlin John LLC purchased a new stake in shares of Intuitive Surgical during the 3rd quarter worth about $30,000. Guerra Advisors Inc purchased a new stake in shares of Intuitive Surgical during the 3rd quarter worth about $37,000. Finally, Riggs Asset Managment Co. Inc. lifted its holdings in shares of Intuitive Surgical by 84.2% during the 2nd quarter. Riggs Asset Managment Co. Inc. now owns 70 shares of the medical equipment provider’s stock valued at $38,000 after buying an additional 32 shares during the last quarter. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity

In related news, VP Fredrik Widman sold 133 shares of the company’s stock in a transaction on Wednesday, February 11th. The shares were sold at an average price of $494.96, for a total transaction of $65,829.68. Following the completion of the sale, the vice president directly owned 660 shares of the company’s stock, valued at approximately $326,673.60. This represents a 16.77% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP Mark Brosius sold 645 shares of the firm’s stock in a transaction on Monday, March 9th. The shares were sold at an average price of $485.01, for a total transaction of $312,831.45. Following the completion of the transaction, the senior vice president owned 1,613 shares in the company, valued at $782,321.13. The trade was a 28.57% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 33,407 shares of company stock valued at $17,534,067 in the last quarter. 0.70% of the stock is currently owned by corporate insiders.

Intuitive Surgical Stock Performance

ISRG opened at $472.16 on Friday. The business has a 50 day moving average price of $513.26 and a 200 day moving average price of $512.67. Intuitive Surgical, Inc. has a twelve month low of $425.00 and a twelve month high of $603.88. The firm has a market cap of $167.68 billion, a P/E ratio of 59.84, a price-to-earnings-growth ratio of 3.64 and a beta of 1.66.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.27 by $0.26. Intuitive Surgical had a return on equity of 15.06% and a net margin of 28.38%.The firm had revenue of $2.87 billion during the quarter, compared to analysts’ expectations of $2.72 billion. During the same quarter in the prior year, the business earned $2.21 earnings per share. The company’s revenue was up 18.8% on a year-over-year basis. As a group, analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities analysts recently commented on ISRG shares. Weiss Ratings restated a “hold (c+)” rating on shares of Intuitive Surgical in a report on Monday, December 29th. HSBC lifted their target price on shares of Intuitive Surgical from $644.00 to $653.00 and gave the company a “buy” rating in a research note on Monday, January 26th. BTIG Research reissued a “buy” rating and issued a $616.00 target price on shares of Intuitive Surgical in a research report on Friday, January 23rd. Raymond James Financial increased their price target on shares of Intuitive Surgical from $603.00 to $615.00 and gave the stock an “outperform” rating in a research note on Friday, January 23rd. Finally, Zacks Research upgraded shares of Intuitive Surgical from a “hold” rating to a “strong-buy” rating in a report on Thursday, February 19th. Two equities research analysts have rated the stock with a Strong Buy rating, sixteen have given a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, Intuitive Surgical currently has an average rating of “Moderate Buy” and an average price target of $615.86.

Key Stories Impacting Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: FDA clearance expands da Vinci 5 into cardiac surgery, opening a much larger long-term TAM (management cites a jump from ~17k to ~160k addressable procedures in cleared markets) — a multi-year growth driver for procedure volume and consumables. Read More.
• Positive Sentiment: Completed acquisition of Southern Europe distributor businesses (Italy, Spain, Portugal) shifts da Vinci and Ion sales to direct operations — should improve control of regional sales/service and capture margin/recurring revenue over time. Read More.
• Positive Sentiment: Sell-side momentum: Citigroup upgraded ISRG to Buy and several analysts maintain bullish price targets, supporting upside thesis and sentiment. Read More.
• Positive Sentiment: Recent Q4 results beat consensus (strong revenue and EPS growth), reinforcing recurring-consumables revenue and the upgrade cycle for da Vinci systems. Read More.
• Neutral Sentiment: Analyst consensus shows meaningful upside (Zacks highlights ~29.7% average target upside), but that depends on execution and multiple expansion remaining intact. Read More.
• Neutral Sentiment: Long-form bullish pieces reiterate a multi-year growth story from da Vinci 5, Ion and software/services but don’t change near-term valuation concerns. Read More.
• Negative Sentiment: Cybersecurity incident (phishing-linked breach affecting internal systems) is the immediate catalyst for the share decline — investors will watch for customer impact, data exposure, and remediation costs. Read More.
• Negative Sentiment: Insider selling (recent EVP share sales) and management guidance calling for a deceleration in worldwide da Vinci procedure growth in 2026 could pressure near-term sentiment and valuation. Read More. • Read More.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.